BIOTHERAPEUTICS DEVELOPABILITY
AND RISK MITIGATION

WORKSHOP ORGANIZERS IN 2024

WORKSHOP n°1 : Cytiva

Wednesday, 25 September 2024

14h00

Accelerate biotech process development

- Pasteur Auditorium

Chairman

10h00

QUALITY CONTROL IN BIOPRODUCTION​

We’re going to talk about how Cytiva supports biopharmaceutical end users from discovery to delivery. With rapid innovation and the ever-growing patient demand for precise, personalized, and effective therapeutics, Cytiva keeps this vision at the center of our business: a world in which access to life-changing therapies transforms human health. Our contribution to that vision is a mission to advance and accelerate therapeutics. We have been in this business quite a few years, nearly 80. We have significant footprint in purification technologies, with 73% of biologics approved using Cytiva technologies. Cytiva currently has 36 manufacturing sites and 23 R&D innovation centers around the world. Over 135 FlexFactory installations have enabled worldwide biomanufacturing expansion for our customers with proven single-use platforms. In this workshop we will introduce Cytiva cell culture custom products and services, microbial control filters, including newly launched Supor™ Prime 0.2 µm sterilizing filters for high concentration biologics, and Fast Trak process development services to enable end users to accelerate their molecules to market through integrated end-to-end solutions and rapid access to capacity & PD experts while customers retain full ownership of the process. We support your needs to build, transfer, or partner whenever it’s right for you.

15h30

End of the workshop

10h30

Workshop Moderators

Logo Mabdesign

Meriem DJEDDOU

Bioprocess Development Scientist

Cytiva, France

Logo Mabdesign

Valentin GIROUX

Bioprocess Cell Culture Sales Specialist

Cytiva, France

Logo Mabdesign

Jesper HEDBERG

Director, Fast Trak PDS EMEA & Testa Center

Testa Center, Sweden

Logo Mabdesign

Marco SANVITO

Bioprocess Senior Regional Marketing Manager

Cytiva, Italy

WORKSHOP n°2 : BioKryo

Wednesday, 25 September 2024

14h00

Business continuity plan : Don’t forget to secure the storage of your biological resources!

- Workshop Room 4

Chairman

10h00

QUALITY CONTROL IN BIOPRODUCTION​

Workshop Room 1

QUALITY CONTROL IN BIOPRODUCTION​

Data Integrity in Healthcare industry & Supply Chain Management

 

Workshop Room 2

QUALITY CONTROL IN BIOPRODUCTION​

USP & DSP development and Industrialisation

15h30

End of the workshop

10h30

Workshop Moderators

Logo Mabdesign

Elodie MILLEROT

Business Developer

BioKryo, France

Logo Mabdesign

Nicolas DEMOURES

Business Developer

BioKryo, France

WORKSHOP n°3 : Waters

Wednesday, 25 September 2024

14h00

Point-of-need analytics and process analytical technologies: 4 case studies

- Workshop Room 3

Chairman

Waters invites you to explore point-of-need analytics for CQA monitoring and process analytical technologies for both upstream and downstream operations, featuring real-world case scenarios.

10h00

POINT-OF-NEED PRODUCT ATTRIBUTE ANALYTICS

From early-stage screening to QA/QC monitoring.

Case Study 1
Early-stage determination of the correct pairing of multi-specific mAbs, using rapid LC-MS and LC-MALS methods.
High-throughput direct identification of constructs and measurement of quality attributes, including glycoforms and low molecular weight components.

 

Case Study 2
Deployment of Multiple-Attribute Method (MAM) for QC Analytical Testing and Replacement of Conventional Methods.
Opportunities and challenges associated with release and stability testing. Zoom on specific features like New Peak Detection to ensure batch production consistency.

10h00

PROCESS ANALYTICAL TECHNOLOGIES

From clone selection and upstream bioprocess development to downstream on-line monitoring.

Case Study 3
Expedite Process Development with Automated PQA and Spent Media Analysis with LC-MS Walkup Solutions.
Rapid product quality attribute (PQA) and media metabolite analysis help understand how process parameters affect product quality and facilitates process troubleshooting.

 

Case Study 4
In-line and on-line monitoring of CQAs for biologics & vaccines by RT-MALS.
This novel PAT characterizes key biophysical attributes and integrates with downstream processes to monitor aggregation, distinguish product from impurities, and identify process endpoints.

15h30

End of the workshop

10h30

Workshop Moderators

Logo Mabdesign

Guillaume BECHADE, PhD

Senior Manager, Global Biologics Marketing

Waters, France

Logo Mabdesign

Mickael HYBOIS

System Sales Team Leader

Waters, France

Logo Mabdesign

Laurent RODRIGUEZ

Application Engineer

Waters | Wyatt Technology, France

WORKSHOP n°4 : Immerscio.bio

Wednesday, 25 September 2024

14h00

Journey to Immerscio.bio new trainings through Virtual Reality, Serious Game and Video Workshops

- Workshop Room 1 & 2

Chairman

10h00

QUALITY CONTROL IN BIOPRODUCTION​

Workshop Room 1

Quality Control in Bioproduction​

Data Integrity in Healthcare industry,

Supply Chain Management

 

Workshop Room 2

Quality Control in Bioproduction

USP & DSP development and Industrialisation

15h30

End of the workshop

10h30

Workshop Moderators

Workshop Room 1

Logo Mabdesign

Gilles FERRY

Innovation Director CMC – Biologics

Servier, France

Logo Mabdesign

Rachel MADEC

Senior Sales & Marketing Manager

Immerscio.bio, France

Logo Mabdesign

Gilles MONTENACH

Head of Digital Workplace

Immerscio.bio, France

Workshop Room 2

Logo Mabdesign

François RAGOT

Bioproduction expert

Consultant for Immerscio.bio, France

Logo Mabdesign

Marc REIS

Service Manager

Immerscio.bio, France

Logo Mabdesign

Michel DUROUX

Commercial Director

Immerscio.bio, France

WORKSHOP n°5 : MabDesign

Thursday, 26 September 2024

11h00

Formation 4.0 : Impact du e-Learning et de l'Intelligence Artificielle

- En Français

- Pasteur Auditorium

Chairman

10h00

QUALITY CONTROL IN BIOPRODUCTION​

Cette table ronde animée par MabDesign explorera l’impact des outils digitaux et de l’intelligence artificielle sur la formation des professionnels dans l’industrie des biomédicaments. Nous examinerons comment, dans le cadre d’un parcours d’apprentissage, le e-learning et les technologies basées sur l’IA révolutionnent les méthodes d’enseignement, permettant des formations plus flexibles, personnalisées et interactives. Les experts discuteront également des attentes des entreprises en matière de recrutement, en particulier sur la nécessité pour les nouveaux talents de combiner des compétences théoriques et techniques traditionnelles avec une connaissance approfondie des technologies digitales.

12h30

Fin de l'atelier

10h30

Modératrice de l'atelier

Logo Mabdesign

Daphné BRISARD

Responsable Formation

MabDesign, France

Logo Mabdesign

Clara ESNAULT

Chargée d'ingénierie de Formation

MabDesign, France

10h30

Panélistes

Virginie DETRY

Fondatrice & CEO

LifeCycle hub, Belgique

Arnaud SCHMUTZ

CEO

Sourcin, Suisse

François RAGOT

Bioproduction expert

Consultant pour Immerscio.bio, France

Sandrine LEMOINE

CEO

Immerscio.bio, France

Joan LECLERC

Responsable Communication et Innovation Digitale

IMT, France

SPONSOR Gold

About us

With a rich heritage dating back hundreds of years, Cytiva brings a wealth of technical expertise and talent, a broad and deep portfolio, and exceptional service help researchers and biopharma advance therapeutics at every stage from discovery to delivery.

 

We supply the tools and support our customers need to work better, faster, and safer, leading to the delivery of transformative medicines to patients. Our combined portfolio includes well-recognized names such as Allegro™, Supor™, iCELLis™, and Kleenpak™, in addition to ÄKTA™, Amersham™, Biacore™, FlexFactory™, HyClone™, MabSelect™, Sefia™, Whatman™, and Xcellerex™.

 

www.cytivalifesciences.com/en/us/solutions/bioprocessing

SPONSOR Silver

About us

With a storage capacity of more than 20 million biological samples, the BioKryo network operates in three European countries, with four dedicated sites. Each site offers a complete range of cryogenic services, including storage temperatures from -196°C to +20°C with all associated services including cryogenic sample transport. This service is destined for research teams in the human and veterinary health sector, pharmaceutical or cosmetic industries, wishing to secure their samples, duplicate their collections or free up space in their premises. Within the BioKryo network, all processes and quality systems are harmonized to meet the highest quality and safety standards for diagnostic, research and therapeutic purposes, wherever a sample is stored. Sample monitoring and traceability is ensured 24/7/365 in a doubled and automatic control by teams of technicians and biologists. All sites comply with Good Manufacturing Practices (GMP) for the reception, storage and provision of biological samples.


https://biokryo.airliquide.com/fr

https://biokryo.airliquide.com/fr/contact

SPONSOR Bronze

About us

Waters Corporation is a global leader in analytical instruments and software, providing innovative solutions for biopharma organizations. Our cutting-edge technologies enhance process efficiency, ensure product quality, and accelerate drug development, enabling our clients to deliver life-saving therapies faster and more effectively. Empowering biopharma organizations and scientists in labs around the world, we deliver scientific insights that unlock the potential of science, to solve problems that matter.

 

www.waters.com/bioprocessing

SPONSOR Silver

About us

Immerscio.bio is an immersive and tailor-made training platform in Bioproduction.

 

immerscio.bio

contact@immerscio.com

SPONSOR Bronze

About us

Sensor Systems for Bioprocess Monitoring

Hamilton process sensors are well known for high quality, long life, unique features, and competitive pricing. In order to meet these rigorous requirements, we are constantly striving to find new ways to design our sensors. As a result of the extensive work by our research and development department, Hamilton is able to offer outstanding solutions for pH, dissolved oxygen, dissolved carbon dioxide, cell density, conductivity and ORP monitoring.

 

www.hamiltoncompany.com/process-analytics

Techsupport.pa.ch@hamilton.ch

Fabien Compeau

Design and development of chemically defined media supplemented with vegetable protein hydrolysates to enhance CHO cell growth and monoclonal antibody production

Abstract

In the realm of biopharmaceutical production, Chinese Hamster Ovary (CHO) cells have emerged as the main expression system for recombinant therapeutic proteins (RTPs), despite the availability of several alternative cell lines. CHO cells are among the most widely used worldwide for their unique advantages, e.g, the variety of post-translational modifications that closely mimic those found on human cells (Stach et al. 2019); their high degree of biosafety due to their low risk of propagation of human viruses infection (Lalonde and Durocher, 2017); their adaptability from adherent to suspension cell culture in serum-free media (Davami et al. 2014). Thanks to these combined attributes that solidified the position of CHO cells, they have become the gold-standard of the bioindustry and are responsible for the production of approximately 70% of all marketed RTPs (Pereira et al., 2018; Stolfa et al., 2018; Dziomba et al. 2023).

 

Fetal bovine serum (FBS) is commonly used as a supplement to basal media for in vitro cell cultures (including mammalian, animal, insect, and bacterial cells). Many studies have revealed its rich composition, containing essential macro- and micronutrients such as growth factors, adherent factors, amino acids, hormones, and vitamins (Michael Butler et al. 2020), which are crucial for proper cell function. In addition to the ethical issue, increasing demand, high cost, significant contamination risks (bacterial and viral), and batch-to-batch variability of FBS prompt us to seek alternatives. To reduce or eliminate FBS use, we have decided to implement culture media with various plant protein hydrolysates. Although serum-free media have been available for several decades, and their widespread adoption has increased, despite the fact that their compositions are undefined for users. Our goal is to make these serum-free media more accessible considering that serum-free media cost about 1.5 to 3 times more than serum-containing media.

 

Several publications highlighted the effects of vegetable proteins hydrolysate (peptones) as supplements in basal media, i.e : the enhancing of the cell growth and productivity of recombinant proteins (Burteau et al. 2003; Michael J. Betenbaugh et al. 2020). Some publications have shown an enhancing of the volumetric productivity more than 100%, and a 40% increase in cell number (Davami et al. 2014; Davami et al. 2015). Then, the composition of these plant hydrolysates varies according to the plant source and the production process. Thanks to their vegetable origins there are neither ethical issues, nor health standards.

 

In the present study, the effect of different peptone concentrations on the CHO-K1 cell line under various culture conditions (adherent/suspension) in a basal medium with a 10-fold reduction of FBS have been evaluated. Supplementation with wheat peptones at defined concentrations increased the viable cell density of CHO-K1 in adherent conditions by 190 – 265%.

 

Additionally, the suspension culture exhibited different results compared to the adherent conditions. In suspension cell culture, only three peptones – wheat, soy, and pea – enhanced viable cell density compared to the medium without hydrolysates. Actually, the only peptone supplementation is not enough to be completely serum-free, but that can reduce the FBS consumption.

Biography

Fabien Compeau is a researcher at both Organotechnie and Université Sorbonne Paris Nord, within the Tissue Engineering Research Unit. With a solid foundation in molecular and cellular biology. His current work centers on developing serum-free media. He completed three years of study at CY Cergy Paris Université and two years at Université Paris Cité. His internships provided valuable experience at the Institut de Recherche Criminelle de la Gendarmerie Nationale, the Institut Jacques Monod, and the Institut Pasteur, his research
focused on cell signaling, dynamics, and differentiation.

Igor Chourpa

Molecular optical spectroscopy as a PAT tool in USP bioprocessing

Abstract

Process analytical technology (PAT) aims at real-time, sampling-free monitoring of bioprocesses, for instance at the upstream stage (USP), when suspensions of CHO (chinese hamster ovary) cells grow in bioreactors and produce monoclonal antibodies (mAbs). The advantages of in-line PAT over the off-line approaches are numerous, from scientific, economic and ecological points of view. Using light as a non-invasive PAT tool is one of the promising ideas that give rise to various technological solutions. Nevertheless, the implementation of novel PAT approaches is limited and still requires further progress in analytical instrumentation and its integration in the whole process.
In this talk, we plan to present a short overview of advances in implementation of molecular optical spectroscopy as a PAT tool in upstream processing of therapeutic antibodies we obtained in the framework of our interdisciplinary research project CLIMB’IN. The project uses analytical spectroscopy based on light absorption and/or multi-angle scattering, both elastic (Rayleigh) and inelastic (Raman) for quantitative monitoring of multiple critical process parameters (CPPs). The advances reached by the CLIMB’IN consortium involve instrumental design and experimental protocols, with a particular focus made on machine learning algorithms. Brought together, these advances allow to improve the relevance and the robustness of the corresponding PAT approaches required for their industrial implementation.

Anne-Sophie GARY

Innovative tools to monitor biological variability of bioprocesses

Abstract

Today, virus-based products like oncolytic viruses and gene therapies are part of the most promising biotherapies. The development of biomanufacturing processes for viral products is not a straight road. It is generally associated with process complexity and biological variability. In depth expression system characterization by adding biological data to standard chemical data will help to understand bioprocesses. With a close collaboration between Naobios and Gensensor, case study from Vero cell substrate-based process will illustrate how transcriptomic data may help to understand and monitor biological variability linked to bioprocesses.

Biography

Anne-Sophie has a PhD in cell biology and is engineer in biotechnology. After working on cell stress and death pathways, Anne-Sophie specialized in the development of advanced therapy medicinal product. Now Principal Scientist at GenSensor, she is in charge of identifying biomarker panels on different expression systems and leads, with her team, the company’s internal research projects and scientific collaborations.